Browse > Article
http://dx.doi.org/10.4062/biomolther.2012.20.2.220

Pectinase-Processed Ginseng Radix (GINST) Ameliorates Hyperglycemia and Hyperlipidemia in High Fat Diet-Fed ICR Mice  

Yuan, Hai-Dan (Department of Pharmacology and Clinical Pharmacy, College of Pharmacy, Kyung Hee University)
Kim, Jung-Tae (Department of Pharmacology and Clinical Pharmacy, College of Pharmacy, Kyung Hee University)
Chung, Sung-Hyun (Department of Pharmacology and Clinical Pharmacy, College of Pharmacy, Kyung Hee University)
Publication Information
Biomolecules & Therapeutics / v.20, no.2, 2012 , pp. 220-225 More about this Journal
Abstract
To develop a ginseng product possessing an efficacy for diabetes, ginseng radix ethanol extract was treated with pectinase and obtained the GINST. In the present study, we evaluate the beneficial effect of GINST on high fat diet (HFD)-induced hyperglycemia and hyperlipidemia and action mechanism(s) in ICR mice. The mice were randomly divided into five groups: regular diet group (RD), high fat diet group (HFD), HFD plus GINST at 75 mg/kg (GINST75), 150 mg/kg (GINST150), and 300 mg/kg (GINST300). Oral glucose tolerance test reveals that GINST improves the glucose tolerance after glucose challenge. Fasting plasma glucose and insulin levels were decreased by 4.3% and 4.2% in GINST75, 10.9% and 20.0% in GINST150, and 19.6% and 20.9% in GINST300 compared to those in HFD control group. Insulin resistance indices were also markedly decreased by 8.2% in GINST75, 28.7% in GINST150, and 36.4% in GINST300, compared to the HFD control group. Plasma triglyceride, total cholesterol and non-esterified fatty acid levels in the GINST300 group were decreased by 13.5%, 22.7% and 24.1%, respectively, compared to those in HFD control group. Enlarged adipocytes of HFD control group were markedly decreased in GINST-treated groups, and shrunken islets of HFD control mice were brought back to near normal shape in GINST300 group. Furthermore, GINST enhanced phosphorylation of AMP-activated protein kinase (AMPK) and glucose transporter 4 (GLUT4). In summary, GINST prevents HFD-induced hyperglycemia and hyperlipidemia through reducing insulin resistance via activating AMPK-GLUT4 pathways, and could be a potential therapeutic agent for type 2 diabetes.
Keywords
Pectinase-processed ginseng radix; High fat diet; Insulin resistance; AMP-activated protein kinase; Glucose transporter 4;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)  (Related Records In Web of Science)
연도 인용수 순위
1 Chiang, C. K., Ho, T. I., Peng, Y. S., Hsu, S. P., Pai. M. F., Yang, S. Y., Hung, K. Y. and Wu, K. D. (2007) Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: effectiveness and side effects. Diabetes Care 30, 3-7.   DOI   ScienceOn
2 Choi, K., Kim, M., Ryu, J. and Choi, C. (2007) Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells. Neurosci. Lett. 421, 37-41.   DOI   ScienceOn
3 Cusi, K. (2010) The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr. Diab. Rep. 10, 306-315.   DOI   ScienceOn
4 Egawa, T., Hamada, T., Ma, X., Karaike, K., Kameda, N., Masuda, S., Iwanaka, N. and Hayashi, T. (2011) Caffeine activates preferentially $\alpha$1-isoform of 5'AMP-activated protein kinase in rat skeletal muscle. Acta. Physiol (Oxf). 201, 227-238.   DOI   ScienceOn
5 Furugen, A., Kobayashi, M., Narumi, K., Watanabe, M., Otake, S., Itagaki, S. and Iseki, K. (2011) AMP-activated protein kinase regulates the expression of monocarboxylate transporter 4 in skeletal muscle. Life Sci. 88, 163-168.   DOI   ScienceOn
6 Han, G. C., Ko, S. K., Sung, J. H. and Chung, S. H. (2007) Compound K enhances insulin secretion with benefi cial metabolic effects in db/ db mice. J. Agric. Food Chem. 55, 10641-10648.   DOI   ScienceOn
7 Kim, Y. M., Namkoong, S., Yun, Y. G., Hong, H. D., Lee, Y. C., Ha, K. S., Lee, H., Kwon, H. J., Kwon, Y. G. and Kim, Y. M. (2007) Water extract of Korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells. Biol. Pharm. Bull. 30, 1674- 1679.   DOI   ScienceOn
8 Kim, D., Y., Yuan, H. D., Chung, I. K. and Chung, S. H. (2009) Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells. J. Agric. Food Chem. 57, 1532-1537.   DOI   ScienceOn
9 Kobayashi, M., Iwata, M. and Haruta, T. (2000) Clinical evaluation of pioglitazone. Nihon Rinsho 58, 395-400.
10 Lee, S. J., Ko, W. G., Kim, J. H., Sung, J.H., Moon, C. K. and Lee, B. H. (2000) Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase- 3 protease. Biochem. Pharmacol. 60, 677-685.   DOI   ScienceOn
11 Liao, Z., Chen, X. and Wu, M. (2010) Antidiabetic effect of fl avones from Cirsium japonicum DC in diabetic rats. Arch. Pharm. Res. 33, 353-362.   DOI
12 Niswender, K. (2010) Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay. Diabetes Obes. Metab. 12, 267-287.   DOI   ScienceOn
13 Liu, X. Q., Wu, L. and Guo, X. J. (2009) Effect of Bu-Zhong-Yi-Qi-Tang on defi ciency of N-glycan/nitric oxide and islet damage induced by streptozotocin in diabetic rats. World J. Gastroenterol. 15, 1730- 1737.   DOI   ScienceOn
14 Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28, 412-419.   DOI   ScienceOn
15 Musi, N. and Goodyear, L. J. (2003) AMP-activated protein kinase and muscle glucose uptake. Acta. Physiol. Scand. 178, 337-345.   DOI   ScienceOn
16 Ryder, J. W., Chibalin, A. V. and Zierath, J. R. (2001) Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle. Acta Physiol. Scand. 171, 249-257.   DOI   ScienceOn
17 Stades, A. M., Heikens, J. T., Erkelens, D. W., Holleman, F. and Hoekstra, J. B. (2004) Metformin and lactic acidosis: cause or coincidence? A review of case reports. J. Intern. Med. 255, 179-187.   DOI   ScienceOn
18 Steinberg, G. R. and Jorgensen, S. B. (2007) The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Rev. Med. Chem. 7, 519-526.
19 Tuttle, K. R., McGill, J. B., Haney, D. J., Lin, T. E. and Anderson, P. W.; PKC-DRS, PKC-DMES, and PKC-DRS 2 Study Groups. (2007) Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease. Clin. J. Am. Soc. Nephrol. 2, 631-636.   DOI   ScienceOn
20 Warren, R. E. (2004) The stepwise approach to the management of type 2 diabetes. Diabetes. Res. Clin. Pract. 65(Suppl 1), S3-8.   DOI
21 Zhang, C., McFarlane, C., Lokireddy, S., Bonala, S., Ge, X., Masuda, S., Gluckman, P. D., Sharma, M. and Kambadur, R. (2011) Myostatin- defi cient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway. Diabetologia 54, 1491-1501.   DOI   ScienceOn
22 Yamamoto, E., Nakamura, T., Kataoka, K., Tokutomi, Y., Dong, Y. F., Fukuda, M., Nako, H., Yasuda, O., Ogawa, H. and Kim-Mitsuyama, S. (2010) Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation. Biochem. Biophys. Res. Commun. 403, 258-263.   DOI
23 Yoon, S. H., Han, E. J., Sung, J. H. and Chung, S. H. (2007) Anti-diabetic effects of compound K versus metformin versus compound Kmetformin combination therapy in diabetic db/db mice. Biol. Pharm. Bull. 30, 2196-2200.   DOI   ScienceOn
24 Yuan, H. D., Kim, S. J. and Chung, S. H. (2011) Benefi cial effects of IH-901 on glucose and lipid metabolisms via activating adenosine monophosphate-activated protein kinase and phosphatidylinositol- 3 kinase pathways. Metabolism 60, 43-51.   DOI   ScienceOn
25 Zhu, C. F., Peng, .H B., Liu, G. Q., Zhang, F. and Li, Y. (2010) Benefi - cial effects of oligopeptides from marine salmon skin in a rat model of type 2 diabetes. Nutrition 26, 1014-1020.   DOI   ScienceOn